0
     

Report Added
Report already added
Impact of COVID-19 on Dermal Filler Market: Segmented; By Type (Biodegradable and non biodegradable) By End user (Calcium Hydroxyl apatite, Fats, Hyaluronic Acid, Poly-L lactic Acid and Others) By Application (Face lift, Facial line correction, Lip enhancement and Others), And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031

Impact of COVID-19 on Dermal Filler Market: Segmented; By Type (Biodegradable and non biodegradable) By End user (Calcium Hydroxyl apatite, Fats, Hyaluronic Acid, Poly-L lactic Acid and Others) By Application (Face lift, Facial line correction, Lip enhancement and Others), And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031

[ 176 + Pages Research Report ] Dermal Filler Market to surpass USD 12.94 billion by 2031 from USD 3.43 billion in 2021 at a CAGR of 13.4% in the coming years, i.e., 2021-31. 

Product Overview
Dermal fillers are gel-like injectable substances that can be used to restore or enhance the structural components of the body. These fillers are commonly used in areas of the face such as the cheeks, jaw, mouth, lip, and the area around the eye. They restore dermal volume and smooth out wrinkles and other facial lines to give the person being treated a younger appearance.

Market Highlights
Global Dermal Filler Market is expected to project a notable CAGR of 13.4% in 2031.

The growing demand for facial aesthetics treatments is a major factor driving the expansion of medical facilities offering such products and services. Another driver expected to boost market growth is the growing elderly population, which will increase demand for dermal fillers to look younger. The emergence of a large number of private and public hospitals, as well as clinics specializing in skin care and dermatology, necessitates the use of dermal fillers. The growing number of these medical facilities all over the world is a significant factor that is expected to lead to market advancements.Global Dermal Filler Market: Segments
A biodegradable segment to grow with the highest CAGR during 2021-31

Based on type, the global Dermal Filler Market is fragmented into Biodegradable and nonbiodegradable. The Biodegradable Dermal Filler Market is expected to account for the lion's share of the market. Because of their safety and enhanced effectiveness, injectable fillers are preferred options. Furthermore, the increasing availability of biodegradable fillers will contribute to market growth. With the growing popularity of long-lasting cosmetic treatments, the market for biodegradable fillers is expected to grow in the coming years.

Hyaluronic Acid providers segment to grow with the highest CAGR during 2021-31

Global Dermal Filler Market is classified based on category into Calcium Hydroxylapatite, Fats, Hyaluronic Acid, Poly-L lactic Acid, and Others. Because it is the gold standard in dermal fillers, hyaluronic acid is expected to account for the largest Global Dermal Filler Market share. The hyaluronic acid segment is being driven by new product launches, and this is expected to drive the Global Dermal Filler Market trend during the forecast period. Other factors expected to drive the growth of the hyaluronic acid segment include the low risk of allergic reactions, the lack of the need for skin testing, and the relatively milder side effects if any.

Lip enhancement segment to grow with the highest CAGR during 2021-31

Based on application, the global Dermal Filler Market is fragmented into Facelift, Facial line correction, Lip enhancement, and Others. Lip enhancement is rapidly gaining popularity, with the market expanding at a rapid pace. Dermal fillers are commonly used for lip augmentation among women to achieve plumper and fuller lips. Furthermore, fillers provide a natural appearance to the lips at a low cost and will thus be widely adopted in the market in the future.Market Dynamics
Drivers

An increasing number of plastic surgeons and per capita disposable income

The rising preference for non-invasive aesthetic procedures, an increasing number of plastic surgeons performing aesthetic procedures, and cost-effective alternatives to cosmetic surgeries are key factors driving the Dermal Filler Market. In addition, rising per capita disposable income fuels the growth of the Global Dermal Filler Market. The rise in dermal filler awareness in both developing and developed countries, as well as the emergence of new products and associated new indications, is propelling the Global Dermal Filler Market revenue.

Rising investments in R&D and fewer complications

Increased investments in research and development for new dermal fillers by major players are also driving sales in the Global Dermal Filler Market. The growth of the Dermal Filler Market is attributed to factors such as the less painful method of treating various facial skin problems, lower occurrences of complications that occur post-surgery, low level of pain, less scarring, and the requirement of smaller incisions. The Dermal Filler Market does not only include facial skin procedures, but also skin aesthetic treatments for other areas of the body. The growing geriatric population has increased the use of anti-aging treatments for skin rejuvenation and collagen restoration. This is also expected to fuel the demand for the dermal filler market.

Restraint
Unregistered practitioners and high cost

The high cost of these fillers is expected to be a significant factor impeding market growth over the forecast period. Furthermore, the presence of unregistered practitioners is expected to have a significant negative impact on the dermal facial fillers market shortly. The negative impact of such fillers is likely to pose a significant challenge to market growth shortly.

Global Dermal Filler Market: Key Players
Merz Pharma
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Sinclair Pharma
Galderma Laboratories
BioPlus Co., Ltd.
Candela Corporation
BIOXIS pharmaceuticals
Suneva Medical
SCULPT Luxury Dermal Fillers Ltd
Dr. Korman Laboratories Ltd. 
Other Prominent Players
Global Dermal Filler Market: Regions
Global Dermal Filler Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The North American market's expansion can be attributed to the rising demand for cosmetic products and the growing demand for minimally invasive facial procedures. Furthermore, the growing clinical trials for innovative skin beauty products are expected to fuel the regional market even further. Among all countries in the region, the United States is expected to make a significant contribution to the region's market development.

Impact of Covid-19 on Dermal Filler Market
COVID-19 has hurt the Dermal Filler Market, which can be attributed to significant disruptions in their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns, as well as other restrictions imposed by governing authorities around the world. Furthermore, consumer demand has subsequently decreased as people are now more focused on eliminating non-essential expenses from their respective budgets as the general economic status of most people has been severely impacted by this outbreak.Global Dermal Filler Market is further segmented by region into:

North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
the Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Global Dermal Filler Market report also contains analysis on:
Dermal Filler Market Segments:

By Type
Biodegradable
Non-biodegradable 
By End-userCalcium HydroxylapatiteFats
Hyaluronic Acid
Poly-L lactic Acid
Others
By Application
Facelift
Facial line correction
Lip enhancement
Others
Dermal Filler Market Dynamics
Dermal Filler Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Dermal Filler Market Report Scope and Segmentation
Report Attribute Details
Market size value in 2021 USD 3.43 billion
The revenue forecast in 2031 USD 12.94 billion
Growth Rate CAGR of 13.4% from 2021 to 2031
The base year for estimation 2020
Quantitative units Revenue in USD million and CAGR from 2021 to 2031
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Type, End-user, Application, and Region
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled Merz Pharma,  Sinclair Pharma, Galderma Laboratories, BioPlus Co., Ltd., Candela Corporation, BIOXIS pharmaceuticals, Suneva Medical, SCULPT Luxury Dermal Fillers Ltd, Dr. Korman Laboratories Ltd..and Other Prominent Players
TABLE OF CONTENTS

Contents
1. Executive Summary
2. Global Dermal Filler Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Dermal Filler Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Dermal Filler Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Dermal Filler Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Type: Market Share (2020-2030F)
12.2.1. Biodegradable, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Non-biodegradable, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
12.3.1. Calcium hydroxyl apatite, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Fats, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Hyaluronic acid, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Poly-L lactic acid, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Other, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. By Application: Market Share (2020-2030F)
12.3.6.1. Face lift, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6.2. Facial line correction, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6.3. Lip enhancement, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6.4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

13. Company Profile
13.1. Merz pharma
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Sinclair Pharma
13.3. Galderma Laboratories
13.4. BioPlus Co., Ltd.
13.5. Candela Corporation
13.6. BIOXIS pharmaceuticals
13.7. Suneva Medical
13.8. SCULPT Luxury Dermal Fillers Ltd
13.9. Dr. Korman Laboratories Ltd.
13.10. Other Prominent Players

14. Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.


















Report Title: Impact of COVID-19 on Dermal Filler Market: Segmented; By Type (Biodegradable and non biodegradable) By End user (Calcium Hydroxyl apatite, Fats, Hyaluronic Acid, Poly-L lactic Acid and Others) By Application (Face lift, Facial line correction, Lip enhancement and Others), And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2031


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Dental Imaging Systems: Global Markets

Dental Imaging Systems: Global Markets

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline